Vivid Dx is a precision diagnostics company spun out of the University of Oxford developing a next-generation platform for rapid pathogen identification and phenotypic antibiotic susceptibility testing (AST) directly from blood without the need for blood culture.
The platform combines novel pathogen cell isolation, Raman spectroscopy, a proprietary Raman spectra database, and AI/ML to deliver broad pathogen ID in ~30 minutes and AST in ~3 hours, targeted at accelerating infectious disease diagnosis and antimicrobial resistance detection.
Leadership & Board
Key Executives
FounderJeff Liu
Current Number of Employees16
Current LinkedIn Followers1,637
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$15M
Total Amount Raised$15M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Vivid Dx had 16 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Vivid Dx had 1,637 followers as of September 14, 2026. The number of followers increased by 8 (0.49%) week-over-week.
1,637Latest Followers Count
8(0.49%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 03, 2026
Seed Round
$15.00M
―
Similar Companies
A snapshot of private companies similar to Vivid Dx, helping you discover and navigate related company profiles.